K
Kathleen R. Merikangas
Researcher at National Institutes of Health
Publications - 480
Citations - 92599
Kathleen R. Merikangas is an academic researcher from National Institutes of Health. The author has contributed to research in topics: Anxiety & Comorbidity. The author has an hindex of 116, co-authored 448 publications receiving 84177 citations. Previous affiliations of Kathleen R. Merikangas include Max Planck Society & University of Pittsburgh.
Papers
More filters
Journal ArticleDOI
Lifetime Prevalence and Age-of-Onset Distributions of DSM-IV Disorders in the National Comorbidity Survey Replication
Ronald C. Kessler,Patricia A. Berglund,Olga Demler,Robert Jin,Kathleen R. Merikangas,Ellen E. Walters +5 more
TL;DR: Lifetime prevalence estimates are higher in recent cohorts than in earlier cohorts and have fairly stable intercohort differences across the life course that vary in substantively plausible ways among sociodemographic subgroups.
Journal ArticleDOI
The epidemiology of major depressive disorder: results from the National Comorbidity Survey Replication (NCS-R).
Ronald C. Kessler,Patricia A. Berglund,Olga Demler,Robert Jin,Doreen S. Koretz,Kathleen R. Merikangas,A. John Rush,Ellen E. Walters,Philip S. Wang +8 more
TL;DR: Notably, major depressive disorder is a common disorder, widely distributed in the population, and usually associated with substantial symptom severity and role impairment, and while the recent increase in treatment is encouraging, inadequate treatment is a serious concern.
Journal ArticleDOI
The Future of Genetic Studies of Complex Human Diseases
TL;DR: The identification of the genetic basis of complex human diseases such as schizophrenia and diabetes has proven difficult as mentioned in this paper, and Risch and Merikangas proposed that they can best accomplish this goal by combining the power of the human genome project with association studies.
Journal ArticleDOI
Lifetime Prevalence of Mental Disorders in U.S. Adolescents: Results from the National Comorbidity Survey Replication-Adolescent Supplement (NCS-A)
Kathleen R. Merikangas,Jian-Ping He,Marcy Burstein,Sonja A. Swanson,Shelli Avenevoli,Lihong Cui,Corina Benjet,Katholiki Georgiades,Joel Swendsen +8 more
TL;DR: Estimates of the lifetime prevalence of DSM-IV mental disorders with and without severe impairment, their comorbidity across broad classes of disorder, and their sociodemographic correlates are presented to provide the first prevalence data on a broad range of mental disorders in a nationally representative sample of U.S. adolescents.
Journal ArticleDOI
Prevalence, severity, and unmet need for treatment of mental disorders in the World Health Organization World Mental Health Surveys.
Koen Demyttenaere,Ronny Bruffaerts,Jose Posada-Villa,Isabelle Gasquet,Kovess,J P Lépine,Matthias C. Angermeyer,Sebastian Bernert,de Girolamo G,Pierluigi Morosini,G Polidori,Takehiko Kikkawa,Norito Kawakami,Y. Ono,Tadashi Takeshima,Hidenori Uda,Elie G. Karam,John Fayyad,A. N. Karam,Zeina Mneimneh,María Elena Medina-Mora,Guilherme Borges,Carmen Lara,de Graaf R,Johan Ormel,Oye Gureje,Shen Y,Y. Huang,Zhang M,Jordi Alonso,Josep Maria Haro,Gemma Vilagut,Evelyn J. Bromet,Semyon Gluzman,C. P. M. Webb,Ronald C. Kessler,Kathleen R. Merikangas,James C. Anthony,Von Korff Mr,Philip S. Wang,Traolach S. Brugha,Sergio Aguilar-Gaxiola,Sing Lee,Steven G. Heeringa,B. E. Pennell,Alan M. Zaslavsky,T. B. Üstün,Somnath Chatterji +47 more
TL;DR: Reallocation of treatment resources could substantially decrease the problem of unmet need for treatment of mental disorders among serious cases and careful consideration needs to be given to the value of treating some mild cases, especially those at risk for progressing to more serious disorders.